Pricing Log in Create free account
Friday 6 November 2026 Export PODD’s income statement to Excel — free account

Insulet Corporation

PODD Healthcare Medical Devices

Insulet Corporation’s revenue for fiscal 2025 (year ended December 2025) was $2.7 billion, up 30.7% from fiscal 2024.

Revenue
+19.2%
EPS
+64.1%
Free cash flow
−29.8%
Total debt
−5.19%

Quarter to September 2026, against a year earlier

145.49 10.63 −6.81%
Market cap
$10.8B
P/E
25.2×
Fwd P/E
24.4×
Dividend yield
—
F-score
6/9
Altman Z
9.09
Beneish M
−2.59
Dividend safety
n/a
Overview Business Profile Earnings & Analysis
Financials
Income Statement Balance Sheet Cash Flow Metrics & Ratios
Segments Valuation Filings

Insulet Corporation (PODD) EV/EBITDA

Alert me on EV/EBITDA

As of 5 November 2026, Insulet Corporation (PODD) trades at a EV/EBITDA of 16.1×. Over the past ten years it has ranged from 0.0× (December 2016) to 1,357× (November 2017); the current reading is higher than 16% of that period. That is above the Medical Devices industry median of 11.5× and above the Healthcare sector median of 8.4×.

EV/EBITDA, daily

Embed this chart

Annual newest first

Period EV/EBITDA Change
FY2025 35.9× (25.37%)
FY2024 48.0× (8.02%)
FY2023 52.2× (74.44%)
FY2022 204× 102.60%
FY2021 101× (35.29%)
FY2020 156× 11.49%
FY2019 140× 20.32%
FY2018 116× (81.81%)
FY2017 639× (9.00%)
FY2016 702× —

Quarterly newest first

Period EV/EBITDA Change
Sep 2026 13.6× (23.73%)
Jun 2026 17.8× (29.18%)
Mar 2026 25.2× (29.79%)
Dec 2025 35.9× (14.45%)
43 more quarters

Against its own ten years

Low 0.0× High 1,357×
Ten-year median 120×
Current reading's percentile 16

EV/EBITDA against peers

Company EV/EBITDA
BIO Bio-Rad Laboratories, Inc. compare n/m
GKOS Glaukos Corporation compare n/m
TXG 10x Genomics compare n/m
BIO.B Bio-Rad Laboratories, Inc. compare n/m
SNN Smith & Nephew SNATS, Inc. compare 6.5×
GMED Globus Medical, Inc. compare 11.9×
PODD Insulet Corporation 16.1×
PEN Penumbra, Inc. compare 57.3×
BRKR Bruker Corporation compare 66.0×
Medical Devices industry median 11.5×
Healthcare sector median 8.4×
Market median 10.9×

What EV/EBITDA is

Enterprise Value over EBITDA tells an investor how the market values a whole company, with debt added and cash taken off, against its operating earnings.

((Stock Price × Shares (Basic, Weighted) (latest quarter)) + (Long Term Debt (Total) (latest quarter) + Current Part of Debt (latest quarter)) − Cash & Short Term Investments (latest quarter)) ÷ EBITDA (TTM)

The full definition of EV/EBITDA →

More on PODD